Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Candel Therapeutics, Inc. | Interim Chief Financial Officer | Common Stock | 62.5K | $405K | $6.47 | Jul 17, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CADL | Candel Therapeutics, Inc. | Jul 17, 2024 | 1 | -$64K | 4 | Jul 19, 2024 | Interim Chief Financial Officer |
CADL | Candel Therapeutics, Inc. | Jul 11, 2024 | 1 | -$53.1K | 4 | Jul 15, 2024 | Interim Chief Financial Officer |
CADL | Candel Therapeutics, Inc. | Jan 12, 2024 | 0 | $0 | 3 | Jan 19, 2024 | Interim Chief Financial Officer; Exhibit 24 - Power of Attorney |